The study focused on a demanding clinical setting: CT-guided renal cryoablation, a minimally invasive procedure in which physicians thread thin, needle-like probes into kidney tumors to freeze and destroy cancerous tissue. These procedures require repeated CT imaging—first to plan the approach, then to confirm probe placement, then to monitor the freezing process and verify the result. Because patients with kidney cancer often undergo serial imaging for diagnosis, treatment, and years of follow-up, their cumulative radiation exposure can add up quickly. Reducing the dose of each scan, even modestly, compounds into a meaningful protective benefit over a patient’s entire course of care.

The researchers designed an elegant experiment that sidestepped a common pitfall in dose-reduction research. Traditionally, scientists either simulate low-dose scans by injecting mathematical noise into routine-dose data, or they irradiate volunteers twice at different dose levels to compare the results directly. The first approach is limited by restricted access to raw projection data; the second raises ethical concerns about unnecessary exposure. Instead, the Mayo team exploited a natural feature of the ablation workflow itself. Each patient already receives a routine-dose planning scan and a lower-dose probe placement check within the same hour, on the same scanner, with the same body habitus. By retrospectively collecting both datasets from fifteen patients, the investigators achieved the statistical power of a paired, dual-acquisition design without adding a single extra milligray of radiation.

The numbers behind the comparison are straightforward. The routine-dose planning scans delivered a volumetric CT dose index of 18.9 plus or minus 4.7 milligrays, while the low-dose probe placement scans delivered 9.9 plus or minus 2.5 milligrays—roughly a fifty percent reduction. The routine-dose images were reconstructed with iDose, a Philips iterative reconstruction algorithm that represents the current clinical standard. The low-dose images were processed with Spectral Precise Image, a newly developed AI-based spectral reconstruction technique that this study was the first in the world to evaluate. Both were benchmarked against filtered back projection, the classical reconstruction mathematics that serves as a common reference point for measuring how much noise each modern algorithm removes.

The quantitative results were striking. Measured in the aorta at the level of the twelfth thoracic vertebra, iterative reconstruction reduced image noise by about 23 percent relative to filtered back projection, at both dose levels. The AI-based spectral reconstruction cut noise by roughly 61 to 62 percent—nearly three times the noise suppression of the clinical standard. Most remarkably, the low-dose images processed by AI were actually 32 percent less noisy than the routine-dose images processed with iterative reconstruction, a difference that was highly statistically significant. In other words, the AI algorithm did not merely compensate for the halved dose; it produced a cleaner image than the higher-dose scan.

Noise reduction alone means little if it comes at the cost of blurred anatomy, a known hazard of aggressive denoising that can give tissue a plastic, unnatural texture. To check for this, the researchers plotted line profiles—mathematical cross-sections of signal intensity—across a renal lesion and through the vertebral foramen, testing how well each algorithm preserved edges in both soft tissue and bone. Compared with filtered back projection, neither iterative nor AI-based reconstruction showed any discernible degradation of anatomic structures. Edge sharpness was well preserved for low-contrast and high-contrast features alike, suggesting the AI engine suppresses noise without smearing the fine boundaries radiologists depend on to localize tumors and plan probe trajectories.

The human verdict came from a blinded reader study. Two radiologists independently rated overall image quality for conventional, 50 kiloelectron volt virtual monoenergetic, and electron density results on a five-point Likert scale, without knowing which dose level or reconstruction algorithm had produced each image. For the conventional images, the low-dose AI protocol scored significantly higher than the routine-dose iterative protocol, at 3.6 versus 3.2, a difference the authors described as superior image quality for the reduced-dose condition. For the 50 keV monoenergetic images, the two protocols were statistically indistinguishable, with both scoring near 3.8 to 3.9. Only the electron density maps, which are intended for quantitative measurement rather than direct visual reading, scored low across the board, with radiologists noting that their texture appeared less realistic.

The technical achievement rests on how the AI reconstruction differs from its predecessors. Spectral CT, also called dual-energy CT, acquires x-ray data at high and low energies, enabling the generation of virtual monoenergetic images, electron density maps, and material-specific images such as iodine or calcium maps. But splitting the data by energy amplifies noise, because the increased dimensionality of energy-selective imaging inherently increases signal variance. Earlier AI reconstruction methods tackled noise in the image domain with convolutional neural networks, or in the projection data before filtered back projection, or by converting sinograms directly into images with deep learning. The Spectral Precise Image technique evaluated here is distinctive in that a single AI model can be applied across all available spectral results—conventional, monoenergetic, and electron density—providing uniform noise control across the entire spectral output of the scanner.

The implications extend well beyond kidney ablations. Interventional radiology is a particularly fertile ground for dose reduction because procedures involve many sequential scans, exposing not only patients but also physicians and care teams to scattered radiation. The authors emphasize that their study establishes feasibility rather than clinical readiness: the cohort of fifteen patients at a single center was small, the patient sizes ranged only from about 29 to 38 centimeters in water equivalent diameter, and the study did not assess diagnostic quality, in which the existence and location of lesions are unknown rather than already established. Slices containing the ablation probes were also excluded to keep readers blinded, a necessary compromise the authors acknowledge as a limitation. Future work, they write, will examine whether diagnostic CT can safely adopt the same dose reductions, how performance varies across body habitus, and how much the AI approach outperforms iterative reconstruction when doses are matched.

Still, the central result is hard to ignore: an AI algorithm, applied to scans using half the radiation, produced images that radiologists judged better than the clinical standard. As deep learning reconstruction matures from a promising laboratory concept into a validated clinical tool, the long-standing assumption that image quality must be purchased with radiation dose is beginning to crumble. For the millions of patients who undergo CT guidance each year—and for the cancer survivors who face decades of surveillance imaging—that crumbling cannot come soon enough.

Subject of Research: AI-based spectral CT reconstruction for radiation dose reduction in image-guided renal ablation

Article Title: Feasibility of radiation dose reduction with AI-based spectral reconstruction for computed tomography

Article References: Feasibility of radiation dose reduction with AI-based spectral reconstruction for computed tomography. (n.d.). https://doi.org/10.1007/s44343-025-00021-3

Image Credits: AI Generated

DOI: 10.1007/s44343-025-00021-3

Keywords: computed tomography, AI reconstruction, radiation dose reduction, spectral CT, deep learning, interventional radiology, renal cryoablation, image quality, virtual monoenergetic imaging, denoising, Mayo Clinic, medical imaging